Skip to Main content Skip to Navigation
Journal articles

IL-15 as a potential target in leukemia

Abstract : Leukemia, one of the most aggressive hematopoietic malignancies, is characterized by excessive proliferation, survival, and impaired differentiation of hematopoietic stem cells. Interleukin 15, a proinflammatory cytokine, induces proliferation and promotes cell survival of human T and B lymphocytes, as well as natural killer cells. However, it may also play a detrimental role in the onset of leukemia. This review provided an overview of the aberrant expression of Interleukin 15 and its role in the development and progression of this hematological malignancy. Also, we critically explored the potential therapeutic opportunities involved in targeting the disruption of interleukin-15 signaling as well as in interleukin-15-mediated enhancement of antitumor immunity.
Complete list of metadata

Cited literature [87 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/hal-01464505
Contributor : Imopa Ul <>
Submitted on : Friday, February 10, 2017 - 11:43:33 AM
Last modification on : Tuesday, October 13, 2020 - 10:45:37 AM
Long-term archiving on: : Thursday, May 11, 2017 - 1:04:40 PM

File

BLCTT-78347-il-15-as-a-potenti...
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Yu Xiong, Danièle Bensoussan, Véronique Decot. IL-15 as a potential target in leukemia. Blood and lymphatic cancer: targets and therapy, Dove Medical Press, 2015, 5, pp.55—63. ⟨10.2147/BLCTT.S78347⟩. ⟨hal-01464505⟩

Share

Metrics

Record views

161

Files downloads

379